ONE-WAYOngoing theme · still written in the latest filings
Four-Business Portfolio: Genomics, CRO, Advanced Medicine and Pathology Diagnostics
The company continues to disclose a business portfolio comprising four reportable segments—genomics, CRO, advanced medicine and pathology diagnostics—and conducts drug discovery support, investment and consulting through its subsidiaries.
Companies3How many companies write about this.
Threads3One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionflat0 helps · 1 hurts · 2 flat